Top Takeaways from HIMSS and the Opportunities in Health IT for 2017

March 13th, 2017
Health IT

Morris, Manning & Martin, LLP and the Metro Atlanta Chamber bring together a panel of experts to share their takeaways from HIMSS and discuss the opportunities in Health IT for 2017.

Panelists
•Kornelius Bankston – Director of Bioscience Ecosystem Expansion, Metro Atlanta Chamber
•Justin Barnes – Healthcare Innovation & Services Strategist
•E Jane Caraway – Director, Georgia Department of Economic Development
•Dr. Denise Hines – CEO of eHealth Services Group & Executive Director of GaHIN
•Michele Madison – Partner, Morris, Manning & Martin, LLP (Moderator)

Read More

Supreme Court Rules on IP Case Life Sciences Manufacturers Are Following

February 24th, 2017
IP/Patents/Trademark, Life Sciences/Pharma, Patents/IP

By Mary An Merchant, Ph.D. / Intellectual Property and Life Sciences Groups – Morris, Manning & Martin, LLP

Do U.S. patent rights protect a patent owner from competitors that export key parts of inventions for reassembly in other countries? Competitive international activity is a common challenge for companies that only hold U.S. patents, especially when deciding whether, and where, to seek patent protection in other countries.  Diagnostic companies, medical device companies and others who hold patents on multicomponent inventions have followed this case closely.

The U.S. Supreme Court answered a part of the question recently, determining that exporting a staple article or commodity of a multicomponent

Read More